Madras High Court Upholds Appointment of District Judges as Tamil Nadu Lokayukta Secretary || Allahabad High Court: IO’s Mere Apprehension Cannot Justify Withholding Seized Items || Patna High Court: Mere Sight of Spouse in Compromising Position doesn't Prove Adultery || Sikkim High Court: POCSO Case not Quashed on Settlement after Survivor Turns Major || Chhattisgarh High Court: Backward Classes Commission Cannot Decide Private Commercial Disputes || SC: Futures & Options Investors Cannot Recover Trading Losses From Professional Clearing Members || Supreme Court: NCTE Executive Committee Can Seek Annual Reports From Teacher Education Institutes || SC: S.362 CrPC Cannot Limit HC’s Inherent Power to Recall Judgment Causing Miscarriage of Justice || Supreme Court Upholds RBI’s Power to Supersede Multi-State Co-op Bank Boards Beyond Six Months || Supreme Court: Retaining Victim in a Specific Role Cannot Reduce Functional Disability

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :